Skip to content

Coronary Sinus Pressure and Microvascular Disease

MACCUS: ModulAtion of Cardiac Coronary Sinus Hemodynamics to Develop a New Treatment for microvascUlar diseaSe. A Single Center, Randomized Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05034224
Acronym
MACCUS
Enrollment
20
Registered
2021-09-05
Start date
2021-08-23
Completion date
2023-08-23
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microvascular Coronary Artery Disease

Brief summary

MACCHUS is a randomized, single-center, controlled, cross-over interventional study in which coronary artery resistances will be measured at baseline and during temporary occlusion of the coronary sinus.

Detailed description

The aim of this study is to test whether an increase in coronary sinus pressure leads to a change in coronary microvascular resistances in patients with angina pectoris and with an indication to measurement of microvascular function as per clinical guidelines. All patients with a clinical indication for the assessment of microvascular function will be invited to participate and will sign the informed consent at least 24 hours before the study. Patients with an index of microvascular resistances \>25 (i.e. evidence of microvascular dysfunction) will undergo study-specific procedures in the same session (i.e. no additional invasive procedure is required for the study). Study-specific procedures include the repetition of the assessment of microvascular resistances at rest and during coronary sinus occlusion. Coronary sinus occlusion will be achieved by inflating a balloon sized to \ 70% of the diameter of the coronary sinus. Since the implantation of a coronary sinus reducer is a therapeutic option for this type of patients, also this procedure (inflation of an undersized balloon in the coronary sinus) provides clinically relevant information (sizing of the vessel, effect on microvascular resistances and feasibility of the intervention). The primary goal of the study is to study the effect of coronary sinus occlusion on microvascular resistances at rest and during hyperemia.

Interventions

DEVICESwan-Ganz catheter placed in the coronary sinus - deflated

A normal Swan-Ganz catheter will be advanced in the coronary sinus. The Balloon will be kept deflated during sham intervention. The index of microvascular resistances will be measured using the Abbott Pressure Wire X as per instructions for use durng both interventions.

DEVICESwan-Ganz catheter placed in the coronary sinus - inflated

A normal Swan-Ganz catheter will be advanced in the coronary sinus. The Balloon will be inflated to obtain coronary sinus occlusion during the active intervention. The index of microvascular resistances will be measured using the Abbott Pressure Wire X as per instructions for use durng both interventions.

Sponsors

Johannes Gutenberg University Mainz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Masking description

Investigators performing the analysis of the data (post-hoc) and patients are blinded to the sequence of the interventions.

Intervention model description

The study is a single-center, cross-over randomized trial to investigate the effect of coronary sinus occlusion on microvascular resistances.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Chronic coronary syndrome (including patients with anginal equivalents). * Reversible ischemia on non-invasive testing, indication to cardiac catheterization; * Indication to the assessment of microvascular function (note: patients will be asked for participation and consented prior to the first measurement of microvascular function, which will be conducted as per clinical indication; only those with evidence of pure or mixed microvascular disease (index of microvascular resistances (IMR)\>25 will proceed into the study); * Willingness to participate and ability to understand, read and sign the informed consent; * Age\>18 years

Exclusion criteria

* Previous CABG with patent grafts to the left anterior descending coronary * Epicardial coronary disease (FFR \<0.80 with evidence of a focal stenosis) in the left anterior descending territory * Severe valvular heart disease * Any cardiomyopathy; pulmonary or renal disease * Inability to provide informed consent * Any disease reducing life expectancy

Design outcomes

Primary

MeasureTime frameDescription
Index of microvascular resistances (balloon occlusion versus deflated balloon)1 Minute after balloon occlusionThe Index of microvascular resistances, calculated as (Pressure distal - coronary venous pressure ) x mean transit time, will be compared between the two arms

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026